Last update :
28/04/2024
References   References 3776  
Type : Manufacturer

Research teams :
Authors :
Title : Omecetaxine (Synribo®) - Summary of Product Characteristics
Reference : Teva Pharmaceuticals 2014

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionOmacetaxine mepesuccinate Anticancer drug
Stability in solutions Glass Sodium chloride 0,9% 3,5 mg/ml 2-8°C Protect from light
24 Hour
Stability in solutions Glass Sodium chloride 0,9% 3,5 mg/ml 25°C Protect from light
12 Hour

  Mentions Légales